Correction: Ellsworth, M.; Ostrosky-Zeichner, L. Isavuconazole: Mechanism of Action, Clinical Efficacy, and Resistance

Authors

• Misti Ellsworth
• Luis Ostrosky-Zeichner

Publication Date

3-17-2025

Journal

Journal of Fungi

DOI

10.3390/jof11030226

PMID

40105014

PMCID

PMC11921056

PubMedCentral® Posted Date

5-17-2025

PubMedCentral® Full Text Version

Post-print

Abstract

In the original article [1], in Section 6.3, “Treatment groups received caspofungin 750 mg IV on day 1” should be “70 mg” instead of “750 mg”. We made a mistake in the process of writing. The corrected paragraph is as follows:

“Treatment groups received caspofungin 70 mg IV on day 1 followed by 50 mg IV daily or 200 mg of isavuconazole IV q8h on days 1–2 followed by 200 mg once daily.”

The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Comments

This corrects the article "Isavuconazole: Mechanism of Action, Clinical Efficacy, and Resistance" in volume 6, 324.

Published Open-Access

yes

Recommended Citation

Misti Ellsworth and Luis Ostrosky-Zeichner, "Correction: Ellsworth, M.; Ostrosky-Zeichner, L. Isavuconazole: Mechanism of Action, Clinical Efficacy, and Resistance" (2025). Faculty, Staff and Student Publications. 3675.
https://digitalcommons.library.tmc.edu/uthmed_docs/3675